New Product Development
Cipla, the leading player in the global drug market announced that its subsidiary InvaGen had entered into formal agreement to acquire US-based specialty pharmaceutical company Avenue Therapeutics from Fortress Biotech for approximately $215 Mn (Rs. 15.6 Bn). The acquisition is anticipated to take place in two phases. As stated by Cipla in a regulatory filing, …
Continue reading “US-based Avenue Therapeutics to be Acquired for $215 Mn by Cipla Subsidiary”
European Union’s wide-ranging team of doctors recently discovered dozen of antibiotic drug resistant bacteria, after which they developed an estimate of five bug types that can lead to substantial death and infection rates. The team found out that according to 2015 stats, over 6, 70,000 individuals were ill and nearly 33,110 met with death. They …
The healthcare system has come a long way over the decades, and is continually evolving to consistently improve the quality of healthcare delivery. Hospital information system has been an impactful technological breakthrough, enabling effective patient records maintenance and efficient patient data management – to aid healthcare professionals in delivering a higher level of experience to …
